137 related articles for article (PubMed ID: 11058865)
21. MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion.
Schroeder JA; Adriance MC; Thompson MC; Camenisch TD; Gendler SJ
Oncogene; 2003 Mar; 22(9):1324-32. PubMed ID: 12618757
[TBL] [Abstract][Full Text] [Related]
22. Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred.
Mukherjee P; Ginardi AR; Madsen CS; Sterner CJ; Adriance MC; Tevethia MJ; Gendler SJ
J Immunol; 2000 Sep; 165(6):3451-60. PubMed ID: 10975866
[TBL] [Abstract][Full Text] [Related]
23. Expression of the human MUC1 mucin cDNA in a hamster pancreatic tumor cell line HP-1.
Batra SK; Metzgar RS; Worlock AJ; Hollingsworth MA
Int J Pancreatol; 1992 Dec; 12(3):271-83. PubMed ID: 1289420
[TBL] [Abstract][Full Text] [Related]
24. Human MUC1 mucin: a potent glandular morphogen.
Hudson MJ; Stamp GW; Chaudhary KS; Hewitt R; Stubbs AP; Abel PD; Lalani EN
J Pathol; 2001 Jul; 194(3):373-83. PubMed ID: 11439371
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of reactivity of anti-MUC1 core protein antibody and killing activity of anti-MUC1 cytotoxic T cells by deglycosylation of target tissues or cells.
Hinoda Y; Takahashi T; Hayashi T; Suwa T; Makiguchi Y; Itoh F; Adachi M; Imai K
J Gastroenterol; 1998 Apr; 33(2):164-71. PubMed ID: 9605944
[TBL] [Abstract][Full Text] [Related]
26. Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors.
Merikhian P; Darvishi B; Jalili N; Esmailinejad MR; Khatibi AS; Kalbolandi SM; Salehi M; Mosayebzadeh M; Barough MS; Majidzadeh-A K; Yadegari F; Rahbarizadeh F; Farahmand L
Mol Oncol; 2022 Jan; 16(2):485-507. PubMed ID: 34694686
[TBL] [Abstract][Full Text] [Related]
27. Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain.
Kalra AV; Campbell RB
Br J Cancer; 2007 Oct; 97(7):910-8. PubMed ID: 17912239
[TBL] [Abstract][Full Text] [Related]
28. In vivo radioiodide imaging and treatment of pancreatic cancer xenografts after MUC1 promoter-driven expression of the human sodium-iodide symporter.
Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Yu FY; Zhou QB; Wang J; Chen JS
Pancreatology; 2007; 7(5-6):505-13. PubMed ID: 17912014
[TBL] [Abstract][Full Text] [Related]
29. Dual Role of the Extracellular Domain of Human Mucin MUC1 in Metastasis.
Syrkina MS; Maslakova AA; Potashnikova DM; Veiko VP; Vassetzky YS; Rubtsov MA
J Cell Biochem; 2017 Nov; 118(11):4002-4011. PubMed ID: 28407289
[TBL] [Abstract][Full Text] [Related]
30. Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration.
Cascio S; Farkas AM; Hughey RP; Finn OJ
Oncotarget; 2013 Oct; 4(10):1686-97. PubMed ID: 24072600
[TBL] [Abstract][Full Text] [Related]
31. Decreased expression of MUC1 induces apoptosis and inhibits migration in pancreatic cancer PANC-1 cells via regulation of Slug pathway.
Zhao P; Meng M; Xu B; Dong A; Ni G; Lu L
Cancer Biomark; 2017 Dec; 20(4):469-476. PubMed ID: 28869438
[TBL] [Abstract][Full Text] [Related]
32. Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines.
Burdick MD; Harris A; Reid CJ; Iwamura T; Hollingsworth MA
J Biol Chem; 1997 Sep; 272(39):24198-202. PubMed ID: 9305871
[TBL] [Abstract][Full Text] [Related]
33. [Human mucin 1 promoter drives human sodium/iodide symporter gene targeting expression in pancreatic carcinoma cells].
Zhou QB; Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Chen JS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2780-4. PubMed ID: 18167272
[TBL] [Abstract][Full Text] [Related]
34. MUC1 mucin core protein binds to the domain 1 of ICAM-1.
Hayashi T; Takahashi T; Motoya S; Ishida T; Itoh F; Adachi M; Hinoda Y; Imai K
Digestion; 2001; 63 Suppl 1():87-92. PubMed ID: 11173916
[TBL] [Abstract][Full Text] [Related]
35. Peanut agglutinin appearance in the blood circulation after peanut ingestion mimics the action of endogenous galectin-3 to promote metastasis by interaction with cancer-associated MUC1.
Zhao Q; Duckworth CA; Wang W; Guo X; Barrow H; Pritchard DM; Rhodes JM; Yu LG
Carcinogenesis; 2014 Dec; 35(12):2815-21. PubMed ID: 25326505
[TBL] [Abstract][Full Text] [Related]
36. Vaccination of mice with MUC1 cDNA suppresses the development of lung metastases.
Kamata M; Denda-Nagai K; Kubota N; Aida S; Takeda K; Irimura T
Clin Exp Metastasis; 2002; 19(8):689-96. PubMed ID: 12553374
[TBL] [Abstract][Full Text] [Related]
37. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
Deguchi T; Tanemura M; Miyoshi E; Nagano H; Machida T; Ohmura Y; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Ito T; Mori M; Doki Y; Sawa Y
Cancer Res; 2010 Jul; 70(13):5259-69. PubMed ID: 20530670
[TBL] [Abstract][Full Text] [Related]
38. In vivo anti-MUC1
Pichinuk E; Chalik M; Benhar I; Ginat-Koton R; Ziv R; Smorodinsky NI; Haran G; Garbar C; Bensussan A; Meeker A; Guillaume T; Rubinstein DB; Wreschner DH
Cancer Immunol Immunother; 2020 Jul; 69(7):1337-1352. PubMed ID: 32219500
[TBL] [Abstract][Full Text] [Related]
39. The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer.
Regimbald LH; Pilarski LM; Longenecker BM; Reddish MA; Zimmermann G; Hugh JC
Cancer Res; 1996 Sep; 56(18):4244-9. PubMed ID: 8797599
[TBL] [Abstract][Full Text] [Related]
40. MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.
Tinder TL; Subramani DB; Basu GD; Bradley JM; Schettini J; Million A; Skaar T; Mukherjee P
J Immunol; 2008 Sep; 181(5):3116-25. PubMed ID: 18713982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
